These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1514 related articles for article (PubMed ID: 31802125)

  • 1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
    Donnelly JP; Chen SC; Kauffman CA; Steinbach WJ; Baddley JW; Verweij PE; Clancy CJ; Wingard JR; Lockhart SR; Groll AH; Sorrell TC; Bassetti M; Akan H; Alexander BD; Andes D; Azoulay E; Bialek R; Bradsher RW; Bretagne S; Calandra T; Caliendo AM; Castagnola E; Cruciani M; Cuenca-Estrella M; Decker CF; Desai SR; Fisher B; Harrison T; Heussel CP; Jensen HE; Kibbler CC; Kontoyiannis DP; Kullberg BJ; Lagrou K; Lamoth F; Lehrnbecher T; Loeffler J; Lortholary O; Maertens J; Marchetti O; Marr KA; Masur H; Meis JF; Morrisey CO; Nucci M; Ostrosky-Zeichner L; Pagano L; Patterson TF; Perfect JR; Racil Z; Roilides E; Ruhnke M; Prokop CS; Shoham S; Slavin MA; Stevens DA; Thompson GR; Vazquez JA; Viscoli C; Walsh TJ; Warris A; Wheat LJ; White PL; Zaoutis TE; Pappas PG
    Clin Infect Dis; 2020 Sep; 71(6):1367-1376. PubMed ID: 31802125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
    De Pauw B; Walsh TJ; Donnelly JP; Stevens DA; Edwards JE; Calandra T; Pappas PG; Maertens J; Lortholary O; Kauffman CA; Denning DW; Patterson TF; Maschmeyer G; Bille J; Dismukes WE; Herbrecht R; Hope WW; Kibbler CC; Kullberg BJ; Marr KA; Muñoz P; Odds FC; Perfect JR; Restrepo A; Ruhnke M; Segal BH; Sobel JD; Sorrell TC; Viscoli C; Wingard JR; Zaoutis T; Bennett JE; ;
    Clin Infect Dis; 2008 Jun; 46(12):1813-21. PubMed ID: 18462102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision)].
    ;
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):754-763. PubMed ID: 32987477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.
    Bassetti M; Azoulay E; Kullberg BJ; Ruhnke M; Shoham S; Vazquez J; Giacobbe DR; Calandra T
    Clin Infect Dis; 2021 Mar; 72(Suppl 2):S121-S127. PubMed ID: 33709127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
    Cornely OA; Hoenigl M; Lass-Flörl C; Chen SC; Kontoyiannis DP; Morrissey CO; Thompson GR;
    Mycoses; 2019 Sep; 62(9):716-729. PubMed ID: 31254420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggers for driving treatment of at-risk patients with invasive fungal disease.
    Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.
    Alexander BD; Lamoth F; Heussel CP; Prokop CS; Desai SR; Morrissey CO; Baddley JW
    Clin Infect Dis; 2021 Mar; 72(Suppl 2):S79-S88. PubMed ID: 33709131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.
    Saxena S; Gee J; Klieger S; Kajon A; Petersen H; Zaoutis T; Fisher B
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):219-225. PubMed ID: 28992290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
    Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
    Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
    Perfect JR; Cornely OA; Heep M; Ostrosky-Zeichner L; Mullane KM; Maher R; Croos-Dabrera R; Lademacher C; Engelhardt M; Chen C; Marty FM
    Mycoses; 2018 Jul; 61(7):420-429. PubMed ID: 29570857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.
    Martinelli AW; Wright CB; Lopes MS; Swayne RL; Krishnamurthy P; Crawley C; Uttenthal B; Follows G; Babar J; Aliyu SH; Enoch DA; Sander CR
    J Med Microbiol; 2022 Jul; 71(7):. PubMed ID: 35819894
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
    Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive fungal disease in heart transplant recipients.
    Rabin AS; Givertz MM; Couper GS; Shea MM; Peixoto D; Yokoe DS; Baden LR; Marty FM; Koo S
    J Heart Lung Transplant; 2015 Feb; 34(2):227-32. PubMed ID: 25455750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of cell-free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients.
    Kushner LE; Schwenk HT; Qin F; Boothroyd D; Aftandilian C
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31133. PubMed ID: 38943234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
    Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
    Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.